Literature DB >> 30385721

TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration.

Sungjin Chung1,2,3, Jessica M Overstreet1,2, Yan Li1,2, Yinqiu Wang1,2, Aolei Niu1,2, Suwan Wang1,2, Xiaofeng Fan1,2, Kensuke Sasaki1,2, Guan-Nan Jin1,2, Stellor Nlandu Khodo1,2, Leslie Gewin1,2, Ming-Zhi Zhang1,2, Raymond C Harris1,2,4.   

Abstract

TGF-β signals through a receptor complex composed of 2 type I and 2 type II (TGF-βRII) subunits. We investigated the role of macrophage TGF-β signaling in fibrosis after AKI in mice with selective monocyte/macrophage TGF-βRII deletion (macrophage TGF-βRII-/- mice). Four weeks after injury, renal TGF-β1 expression and fibrosis were higher in WT mice than macrophage TGF-βRII-/- mice, which had decreased renal macrophages. The in vitro chemotactic response to f-Met-Leu-Phe was comparable between bone marrow-derived monocytes (BMMs) from WT and macrophage TGF-βRII-/- mice, but TGF-βRII-/- BMMs did not respond to TGF-β. We then implanted Matrigel plugs suffused with either f-Met-Leu-Phe or TGF-β1 into WT or macrophage TGF-βRII-/- mice. After 6 days, f-Met-Leu-Phe induced similar macrophage infiltration into the Matrigel plugs of WT and macrophage TGF-βRII-/- mice, but TGF-β induced infiltration only in WT mice. We further determined the number of labeled WT or TGF-βRII-/- BMMs infiltrating into WT kidneys 20 days after ischemic injury. There were more labeled WT BMMs than TGF-βRII-/- BMMs. Therefore, macrophage TGF-βRII deletion protects against the development of tubulointerstitial fibrosis following severe ischemic renal injury. Chemoattraction of macrophages to the injured kidney through a TGF-β/TGF-βRII axis is a heretofore undescribed mechanism by which TGF-β can mediate renal fibrosis during progressive renal injury.

Entities:  

Keywords:  Chemokines; Fibrosis; Macrophages; Nephrology

Mesh:

Substances:

Year:  2018        PMID: 30385721      PMCID: PMC6238749          DOI: 10.1172/jci.insight.123563

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  37 in total

1.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

2.  Deleting the TGF-β receptor attenuates acute proximal tubule injury.

Authors:  Leslie Gewin; Sangeetha Vadivelu; Surekha Neelisetty; Manakan B Srichai; Paisit Paueksakon; Ambra Pozzi; Raymond C Harris; Roy Zent
Journal:  J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 10.121

3.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.

Authors:  G S Ashcroft; X Yang; A B Glick; M Weinstein; J L Letterio; D E Mizel; M Anzano; T Greenwell-Wild; S M Wahl; C Deng; A B Roberts
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

4.  Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.

Authors:  Ming-Zhi Zhang; Yinqiu Wang; Bing Yao; Leslie Gewin; Shouzuo Wei; Jorge H Capdevila; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

5.  Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice.

Authors:  M Ferron; J Vacher
Journal:  Genesis       Date:  2005-03       Impact factor: 2.487

6.  TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis.

Authors:  Simona Serratì; Francesca Margheri; Marco Pucci; Anna Rita Cantelmo; Rosaria Cammarota; Javier Dotor; Francisco Borràs-Cuesta; Gabriella Fibbi; Adriana Albini; Mario Del Rosso
Journal:  Biochem Pharmacol       Date:  2008-11-12       Impact factor: 5.858

7.  Origin and function of myofibroblasts in kidney fibrosis.

Authors:  Valerie S LeBleu; Gangadhar Taduri; Joyce O'Connell; Yingqi Teng; Vesselina G Cooke; Craig Woda; Hikaru Sugimoto; Raghu Kalluri
Journal:  Nat Med       Date:  2013-06-30       Impact factor: 53.440

8.  Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.

Authors:  Tianju Liu; Biao Hu; Yoon Young Choi; Myoungja Chung; Matthew Ullenbruch; Hongfeng Yu; John B Lowe; Sem H Phan
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

9.  Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy.

Authors:  Xin Wang; Bing Yao; Yinqiu Wang; Xiaofeng Fan; Suwan Wang; Aolei Niu; Haichun Yang; Agnes Fogo; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2016-11-04       Impact factor: 9.461

10.  Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.

Authors:  Surekha Neelisetty; Catherine Alford; Karen Reynolds; Luke Woodbury; Stellor Nlandu-Khodo; Haichun Yang; Agnes B Fogo; Chuan-Ming Hao; Raymond C Harris; Roy Zent; Leslie Gewin
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

View more
  32 in total

Review 1.  The many talents of transforming growth factor-β in the kidney.

Authors:  Leslie Gewin
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-05       Impact factor: 2.894

Review 2.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

Review 3.  Transforming Growth Factor-β in the Acute Kidney Injury to Chronic Kidney Disease Transition.

Authors:  Leslie S Gewin
Journal:  Nephron       Date:  2019-04-30       Impact factor: 2.847

Review 4.  Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.

Authors:  Michael Rauchman; David Griggs
Journal:  Transl Res       Date:  2019-04-24       Impact factor: 7.012

5.  Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Authors:  Hiroki Kobayashi; Helen C Looker; Eiichiro Satake; Francesca D'Addio; Jonathan M Wilson; Pierre Jean Saulnier; Zaipul I Md Dom; Kristina O'Neil; Katsuhito Ihara; Bozena Krolewski; Hannah S Badger; Adriana Petrazzuolo; Domenico Corradi; Andrzej Galecki; Parker C Wilson; Behzad Najafian; Michael Mauer; Monika A Niewczas; Alessandro Doria; Benjamin D Humphreys; Kevin L Duffin; Paolo Fiorina; Robert G Nelson; Andrzej S Krolewski
Journal:  Sci Transl Med       Date:  2022-08-10       Impact factor: 19.319

6.  Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion.

Authors:  Hui Geng; Rongpei Lan; Yaguang Liu; Wei Chen; Meng Wu; Pothana Saikumar; Joel M Weinberg; Manjeri A Venkatachalam
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-11

7.  Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.

Authors:  Divya Bhatia; Kuei-Pin Chung; Kiichi Nakahira; Edwin Patino; Michelle C Rice; Lisa K Torres; Thangamani Muthukumar; Augustine Mk Choi; Oleh M Akchurin; Mary E Choi
Journal:  JCI Insight       Date:  2019-12-05

8.  HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways.

Authors:  Jeffrey Laurence; Sonia Elhadad; Sandra Gostynska; Zhongxin Yu; Hunter Terry; Rohan Varshney; Kar-Ming Fung; Mary E Choi; Jasimuddin Ahamed
Journal:  AIDS       Date:  2020-06-01       Impact factor: 4.632

Review 9.  Renal Inflammation and Fibrosis: A Double-edged Sword.

Authors:  Laurence M Black; Jeremie M Lever; Anupam Agarwal
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 10.  The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney.

Authors:  Craig E Higgins; Jiaqi Tang; Stephen P Higgins; Cody C Gifford; Badar M Mian; David M Jones; Wenzheng Zhang; Angelica Costello; David J Conti; Rohan Samarakoon; Paul J Higgins
Journal:  Front Cell Dev Biol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.